These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 901551)

  • 21. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S; Briley MS; Dubocovich ML; Langer SZ
    Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood-brain barrier. II. Kinetics of distribution of 3H-parahydroxyamphetamine in brain structures after intravenous administration in the rat].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):168-76. PubMed ID: 1164084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ascending catecholamine systems and morphine analgesia.
    Price MT; Fibiger HC
    Brain Res; 1975 Nov; 99(1):189-93. PubMed ID: 1188982
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 25. Amphetamine, p-hydroxyamphetamine and beta-phenethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration.
    Philips SR
    J Pharm Pharmacol; 1981 Nov; 33(11):739-41. PubMed ID: 6118419
    [No Abstract]   [Full Text] [Related]  

  • 26. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
    Kuczenski R
    Neuropharmacology; 1975 Jan; 14(1):1-10. PubMed ID: 239360
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence that alpha-methyl-p-tyramine is implicated in behavioural augmentation to amphetamine.
    Dougan DF; Labrie SL; Paull PD; Duffield PH; Wade DN
    Gen Pharmacol; 1986; 17(4):453-6. PubMed ID: 3758652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catecholamines and convulsions.
    Mason ST; Corcoran ME
    Brain Res; 1979 Jul; 170(3):497-507. PubMed ID: 466425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Azzaro AJ; Rutledge CO
    Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
    [No Abstract]   [Full Text] [Related]  

  • 32. 4-OH amphetamine enhances retention of an active avoidance response in rats and decreases regional brain concentrations of norepinephrine and dopamine.
    Martinez JL; Ishikawa K; Liang KC; Jensen RA; Bennett C; Sternberg DB; McGaugh JL
    Behav Neurosci; 1983 Dec; 97(6):962-9. PubMed ID: 6651966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport of dopamine in discrete areas of the striatum and of cerebral cortex in the rat.
    Tassin JP; Blanc G; Stinus L; Berger B; Glowinski J; Thierry AM
    Adv Exp Med Biol; 1976; 69():337-45. PubMed ID: 941742
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 36. Liquid chromatographic analysis of endogenous catecholamine release from brain slices.
    Plotsky PM; Wightman RM; Chey W; Adams RN
    Science; 1977 Aug; 197(4306):904-6. PubMed ID: 887928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics and metabolism of amphetamine in the brain of rats of different ages.
    Honecker H; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):111-21. PubMed ID: 1202363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine-induced release of catecholamines from rat hippocampus and striatum.
    Arqueros L; Naquira D; Zunino E
    Biochem Pharmacol; 1978; 27(23):2667-74. PubMed ID: 728222
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychobiological foundations of behaviors induced by amphetamines.
    Groves PM; Segal DS
    NIDA Res Monogr; 1984; 54():356-66. PubMed ID: 6099879
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of catecholamine development following unilateral diencephalic lesions in the neonatal rat.
    Erinoff L; Heller A
    Brain Res; 1973 Aug; 58(2):489-93. PubMed ID: 4756139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.